Prognostic Nomograms Based on Ground Glass Opacity and Subtype of Lung Adenocarcinoma for Patients with Pathological Stage IA Lung Adenocarcinoma

被引:5
|
作者
Zhai, Wenyu [1 ]
Liang, Dachuan [1 ]
Duan, Fangfang [2 ]
Wong, Wingshing [1 ]
Yan, Qihang [3 ]
Gong, Li [1 ]
Lai, Renchun [4 ]
Dai, Shuqin [5 ]
Long, Hao [1 ]
Wang, Junye [1 ]
机构
[1] Sun Yat Sen Univ, Dept Thorac Surg, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Canc Ctr, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Dept Med Oncol, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Canc Ctr, Guangzhou, Peoples R China
[3] Zhejiang Univ, Dept Thorac Surg, Affiliated Hosp 2, Sch Med, Hangzhou, Peoples R China
[4] Sun Yat Sen Univ, Dept Anaesthesiol, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Canc Ctr, Guangzhou, Peoples R China
[5] Sun Yat Sen Univ, Dept Lab Med, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Canc Ctr, Guangzhou, Peoples R China
来源
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY | 2021年 / 9卷
关键词
lung adenocarcinoma; pathological subtype; GGO (ground glass opacity); nomogram; prognosis; PREDOMINANT HISTOLOGIC SUBTYPE; FACTOR RECEPTOR MUTATION; EGFR MUTATION; INTERNATIONAL ASSOCIATION; FREE SURVIVAL; CLASSIFICATION; CANCER; MICROPAPILLARY; IMPACT; CT;
D O I
10.3389/fcell.2021.769881
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The value of lung adenocarcinoma (LUAD) subtypes and ground glass opacity (GGO) in pathological stage IA invasive adenocarcinoma (IAC) has been poorly understood, and reports of their association with each other have been limited. In the current study, we retrospectively reviewed 484 patients with pathological stage IA invasive adenocarcinoma (IAC) at Sun Yat-sen University Cancer Center from March 2011 to August 2018. Patients with at least 5% solid or micropapillary presence were categorized as high-risk subtypes. Independent indicators for disease-free survival (DFS) and overall survival (OS) were identified by multivariate Cox regression analysis. Based on these indicators, we developed prognostic nomograms of OS and DFS. The predictive performance of the two nomograms were assessed by calibration plots. A total of 412 patients were recognized as having the low-risk subtype, and 359 patients had a GGO. Patients with the low-risk subtype had a high rate of GGO nodules (p < 0.001). Multivariate Cox regression analysis showed that the high-risk subtype and GGO components were independent prognostic factors for OS (LUAD subtype: p = 0.002; HR 3.624; 95% CI 1.263-10.397; GGO component: p = 0.001; HR 3.186; 95% CI 1.155-8.792) and DFS (LUAD subtype: p = 0.001; HR 2.284; 95% CI 1.448-5.509; GGO component: p = 0.003; HR 1.877; 95% CI 1.013-3.476). The C-indices of the nomogram based on the LUAD subtype and GGO components to predict OS and DFS were 0.866 (95% CI 0.841-0.891) and 0.667 (95% CI 0.586-0.748), respectively. Therefore, the high-risk subtype and GGO components were potential prognostic biomarkers for patients with stage IA IAC, and prognostic models based on these indicators showed good predictive performance and satisfactory agreement between observational and predicted survival.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Ground-glass opacity-featured lung adenocarcinoma has no response to chemotherapy
    Zhang, Yang
    Deng, Chaoqiang
    Ma, Xiao
    Gao, Zhendong
    Wang, Shengping
    Zheng, Qiang
    Xia, Guozhan
    Wen, Zhexu
    Han, Han
    Fu, Fangqiu
    Liu, Quan
    Hu, Hong
    Li, Yuan
    Wong, Kwok-Kin
    Chen, Haiquan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (09) : 2411 - 2417
  • [42] Solid tumors versus mixed tumors with a ground-glass opacity component in patients with clinical stage IA lung adenocarcinoma: Prognostic comparison using high-resolution computed tomography findings
    Tsutani, Yasuhiro
    Miyata, Yoshihiro
    Yamanaka, Takeharu
    Nakayama, Haruhiko
    Okumura, Sakae
    Adachi, Shuji
    Yoshimura, Masahiro
    Okada, Morihito
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2013, 146 (01) : 17 - 23
  • [43] Predicting pathological lymph node status in clinical stage IA peripheral lung adenocarcinoma
    Aokage, Keiju
    Suzuki, Kenji
    Wakabayashi, Masashi
    Mizutani, Tomonori
    Hattori, Aritoshi
    Fukuda, Haruhiko
    Watanabe, Shun-Ichi
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2021, 60 (01) : 64 - 71
  • [44] Negative prognostic influence of micropapillary pattern in stage IA lung adenocarcinoma
    Tsubokawa, Norifumi
    Mimae, Takahiro
    Sasada, Shinsuke
    Yoshiya, Tomoharu
    Mimura, Takeshi
    Murakami, Shuji
    Ito, Hiroyuki
    Miyata, Yoshihiro
    Nakayama, Haruhiko
    Okada, Morihito
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2016, 49 (01) : 293 - 299
  • [45] A Novel Radiopathological Grading System to Tailor Recurrence Risk for Pathologic Stage IA Lung Adenocarcinoma
    Qiu, Zhen-Bin
    Wang, Meng-Min
    Yan, Jin-Hai
    Zhang, Chao
    Wu, Yi-Long
    Zhang, Sheng
    Zhong, Wen-Zhao
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2023, 35 (03) : 594 - 602
  • [46] Pan-Driver-Negatives versus Epidermal Growth Factor Receptor Mutants for C-Stage IA Lung Adenocarcinoma with Ground-Glass Opacity
    Li, Ming
    Xi, Junjie
    Zhang, Huan
    Jin, Xing
    Zhang, Jianrong
    Feng, Mingxiang
    Zhan, Cheng
    Wang, Qun
    ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, 2022, 28 (05) : 320 - 328
  • [47] Radiofrequency Ablation for Ground-Glass Opacity-Dominant Lung Adenocarcinoma
    Kodama, Hiroshi
    Yamakado, Koichiro
    Hasegawa, Takaaki
    Takao, Motoshi
    Taguchi, Osamu
    Fukai, Ichiro
    Sakuma, Hajime
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2014, 25 (03) : 333 - 339
  • [48] Prognostic significance using histologic subtype in stage I lung adenocarcinoma
    Jeon, Hyun Woo
    Kim, Young-Du
    Sim, Sung Bo
    Moon, Mi Hyoung
    JOURNAL OF THORACIC DISEASE, 2024, 16 (10) : 6760 - 6769
  • [49] Prognostic significance and survival benefits of postoperative adjuvant chemotherapy in patients with stage IA lung adenocarcinoma with non-predominant micropapillary components
    Li, Rongyang
    Qiu, Jianhao
    Li, Zhenyi
    Li, Haiming
    Tang, Zhanpeng
    Yu, Wenhao
    Tian, Hui
    Sun, Zhenguo
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2024, 22 (01)
  • [50] Clinical implication of minimal presence of solid or micropapillary subtype in early-stage lung adenocarcinoma
    Choi, Sun Ha
    Jeong, Ji Yun
    Lee, Shin Yup
    Shin, Kyung Min
    Jeong, Shin Young
    Park, Tae-In
    Do, Young Woo
    Lee, Eung Bae
    Seok, Yangki
    Lee, Won Kee
    Park, Ji Eun
    Park, Sunji
    Lee, Yong Hoon
    Seo, Hyewon
    Yoo, Seung Soo
    Lee, Jaehee
    Cha, Seung-Ick
    Kim, Chang Ho
    Park, Jae Yong
    THORACIC CANCER, 2021, 12 (02) : 235 - 244